| Trial ID: | L0421 |
| Source ID: | ChiCTR2000035261
|
| Associated Drug: |
Lycopene supplementation
|
| Title: |
Effect and mechanism of lycopene supplementation on iron overload in nonalcoholic fatty liver Patients
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver Disease (NAFLD)
|
| Interventions: |
Healthy control group:None;Placebo control group:Placebo ;Low dose lycopene intervention group:20 mg/d lycopene;High dose lycopene intervention group:40 mg/d lycopene;
|
| Outcome Measures: |
Hemoglobin;Serum ferritin;Serum iron;Soluble transferrin receptor;Alanine aminotransferase;Aspartate aminotransferase;Total protein;Albumin;Hepcidin;Hemojuvelin;Height;Weight;Waist circumference;Hip circumference;Abdominal circumference;Inflammatory cytokines;
|
| Sponsor/Collaborators: |
Qingdao University
|
| Gender: |
All
|
| Age: |
3060
|
| Phases: |
Phase 0
|
| Enrollment: |
Healthy control group:50;Placebo control group:50;Low dose lycopene intervention group:50;High dose lycopene intervention group:50;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Parallel
|
| Start Date: |
05/08/2020
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
10 August 2020
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=57516
|
